Ticker Symbol | Entity Name | As Of Date | Company Name | Followers | Employees on Linkedin | Link | Industry | Date Added | Date Updated | Description | Website | Specialities | Logo | HQ.Street | HQ.City | HQ.State | HQ.Country | HQ.Postal | Headcount change in past 24 months | Company Name | Sector | Industry |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
nasdaq:obsv | 5282629 | Mar 23rd, 2024 12:00AM | ObsEva SA | 3.0K | 18.00 | Open | Mar 23rd, 2024 12:02AM | Mar 23rd, 2024 07:11PM | Innovating Women’s Reproductive Health and Pregnancy Therapeutics ObsEva is a clinical-stage biopharmaceutical company focused on the clinical development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. For more information, please visit www.ObsEva.com. | Open | Open | Plan-Les-Ouates | Geneva | CH | 1228 | ObsEva SA | ||||||
nasdaq:obsv | 5282629 | Mar 22nd, 2024 12:00AM | ObsEva SA | 3.0K | 18.00 | Open | Mar 21st, 2024 11:52PM | Mar 22nd, 2024 06:59PM | Innovating Women’s Reproductive Health and Pregnancy Therapeutics ObsEva is a clinical-stage biopharmaceutical company focused on the clinical development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. For more information, please visit www.ObsEva.com. | Open | Open | Plan-Les-Ouates | Geneva | CH | 1228 | ObsEva SA | ||||||
nasdaq:obsv | 5282629 | Mar 21st, 2024 12:00AM | ObsEva SA | 3.0K | 18.00 | Open | Mar 21st, 2024 12:05AM | Mar 21st, 2024 05:43PM | Innovating Women’s Reproductive Health and Pregnancy Therapeutics ObsEva is a clinical-stage biopharmaceutical company focused on the clinical development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. For more information, please visit www.ObsEva.com. | Open | Open | Plan-Les-Ouates | Geneva | CH | 1228 | ObsEva SA | ||||||
nasdaq:obsv | 5282629 | Mar 20th, 2024 12:00AM | ObsEva SA | 3.0K | 18.00 | Open | Mar 20th, 2024 12:46AM | Mar 20th, 2024 07:44PM | Innovating Women’s Reproductive Health and Pregnancy Therapeutics ObsEva is a clinical-stage biopharmaceutical company focused on the clinical development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. For more information, please visit www.ObsEva.com. | Open | Open | Plan-Les-Ouates | Geneva | CH | 1228 | ObsEva SA | ||||||
nasdaq:obsv | 5282629 | Mar 19th, 2024 12:00AM | ObsEva SA | 3.0K | 18.00 | Open | Mar 18th, 2024 11:40PM | Mar 19th, 2024 06:16PM | Innovating Women’s Reproductive Health and Pregnancy Therapeutics ObsEva is a clinical-stage biopharmaceutical company focused on the clinical development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. For more information, please visit www.ObsEva.com. | Open | Open | Plan-Les-Ouates | Geneva | CH | 1228 | ObsEva SA | ||||||
nasdaq:obsv | 5282629 | Mar 18th, 2024 12:00AM | ObsEva SA | 3.0K | 18.00 | Open | Mar 18th, 2024 12:02AM | Mar 18th, 2024 07:28PM | Innovating Women’s Reproductive Health and Pregnancy Therapeutics ObsEva is a clinical-stage biopharmaceutical company focused on the clinical development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. For more information, please visit www.ObsEva.com. | Open | Open | Plan-Les-Ouates | Geneva | CH | 1228 | ObsEva SA | ||||||
nasdaq:obsv | 5282629 | Mar 16th, 2024 12:00AM | ObsEva SA | 3.0K | 18.00 | Open | Mar 15th, 2024 11:31PM | Mar 16th, 2024 07:15PM | Innovating Women’s Reproductive Health and Pregnancy Therapeutics ObsEva is a clinical-stage biopharmaceutical company focused on the clinical development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. For more information, please visit www.ObsEva.com. | Open | Open | Plan-Les-Ouates | Geneva | CH | 1228 | ObsEva SA | ||||||
nasdaq:obsv | 5282629 | Mar 15th, 2024 12:00AM | ObsEva SA | 3.0K | 18.00 | Open | Mar 15th, 2024 01:19AM | Mar 15th, 2024 09:05AM | Innovating Women’s Reproductive Health and Pregnancy Therapeutics ObsEva is a clinical-stage biopharmaceutical company focused on the clinical development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. For more information, please visit www.ObsEva.com. | Open | Open | Plan-Les-Ouates | Geneva | CH | 1228 | ObsEva SA | ||||||
nasdaq:obsv | 5282629 | Mar 14th, 2024 12:00AM | ObsEva SA | 3.0K | 18.00 | Open | Mar 13th, 2024 11:30PM | Mar 14th, 2024 12:27PM | Innovating Women’s Reproductive Health and Pregnancy Therapeutics ObsEva is a clinical-stage biopharmaceutical company focused on the clinical development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. For more information, please visit www.ObsEva.com. | Open | Open | Plan-Les-Ouates | Geneva | CH | 1228 | ObsEva SA | ||||||
nasdaq:obsv | 5282629 | Mar 13th, 2024 12:00AM | ObsEva SA | 3.0K | 18.00 | Open | Mar 12th, 2024 11:24PM | Mar 13th, 2024 10:57AM | Innovating Women’s Reproductive Health and Pregnancy Therapeutics ObsEva is a clinical-stage biopharmaceutical company focused on the clinical development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. For more information, please visit www.ObsEva.com. | Open | Open | Plan-Les-Ouates | Geneva | CH | 1228 | ObsEva SA |